The invention is directed to hydrophilic and hydrophobic superparamagnetic nanoparticles and their use as contrast agents for NMR including agents that distinguish oil and water in NMR logging of geological formations containing oil or water. Methods of making these SPIONs are also described.

A method for making crown ether functionalized substrates, which includes modifying crown ether-based molecules by reacting with carboxylic acid functionalize chains. The crown ether-based molecules are then attached to substrates, thereby forming crown ether functionalized substrates.

A method for the isolation, or isolation and detection, of circulating tumor cells (CTCs) from blood or lymph, or disseminated tumor cells (DTCs) from bone marrow. CDCP1 is used as a biomarker for the isolation of CTCs or DTCs having a mesenchymal phenotype (mCTC, mDTC) or a hybrid epithelial/mesenchymal phenotype (emCTC, emDTC). Isolation can, for example, be done immunomagnetically using anti-CDCP1 antibodies coupled to magnetic particles.

An apparatus is provided which comprises: a magnetic junction including: a first structure comprising a magnet with an unfixed perpendicular magnetic anisotropy (PMA) relative to an x-y plane of a device; a second structure comprising one of a dielectric or metal; a third structure comprising a magnet with fixed PMA, wherein the third structure has an anisotropy axis perpendicular to the plane of the device, and wherein the third structure is adjacent to the second structure such that the second structure is between the first and third structures; a fourth structure comprising an antiferromagnetic (AFM) material, the fourth structure adjacent to the third structure; a fifth structure comprising a magnet with PMA, the fifth structure adjacent to the fourth structure; and an interconnect adjacent to the first structure, the interconnect comprising spin orbit material.

Provided are a novel immuno-optomagnetic point-of-care (PoC) assay and in particular, a method for detecting an analyte using magnetic nanoparticles and quantum dots (QD) having antibodies which are interfaced with the fabricated PoC biochip platform for quantitative analysis, and an immuno-optomagnetic detection method. The method also relates to methods of making such a plurality of conjugated magnetic quantum dot nanoparticles, methods of detecting analytes using such a plurality of conjugated quantum dot nanoparticles.

The disclosure provides nanoemulsion compositions and methods of making and using thereof to deliver a bioactive agent such as a nucleic acid to a subject. The nanoemulsion composition comprises a hydrophobic core based on inorganic nanoparticles in a lipid nanoparticle that allows imaging as well as delivering nucleic acids. Methods of using these particles for treatment and vaccination are also provided.

Systems and methods for automated sample preparation and processing of protein corona are described herein, as well as its application in the discovery of advanced diagnostic tools as well as therapeutic agents.

A nanocomposite particle and a magnetron display device are disclosed. The nanocomposite particle includes a magnetic core, and a first protection layer and a luminescent that sequentially cover the magnetic core. A length of the nanocomposite particle in a long axis direction is different from a length of the nanocomposite particle in a short axis direction.

A multiplier is formed from a plurality of nanomagnetic structures including slant edge input nanomagnetic structures, diagonal elongate interconnect nanomagnetic structures, and output nanomagnetic structures. Input logic levels are provided by inserting a magnetic field, which generates an set of output magnetic fields representing the product of the binary input values.

The embodiments of the present disclosure relate to a method, system and composition producing a magnetic carbon nanomaterial product that may comprise carbon nanotubes (CNTs) at least some of which are magnetic CNTs (mCNTs). The method and apparatus employ carbon dioxide (CO.sub.2) as a reactant in an electrolysis reaction in order to make mCNTs. In some embodiments of the present disclosure, a magnetic additive component is included as a reactant in the method and as a portion of one or more components in the system or composition to facilitate a magnetic material addition process, a carbide nucleation process or both during the electrosynthesis reaction for making magnetic carbon nanomaterials.